Free Trial

Evogene (EVGN) Stock Forecast & Price Target

$0.60
+0.01 (+1.70%)
(As of 07/19/2024 ET)

Evogene - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 3 Wall Street analysts who have issued ratings for Evogene in the last 12 months, the stock has a consensus rating of "Buy." Out of the 3 analysts, 3 have given a buy rating for EVGN.

Consensus Price Target

$3.62
502.88% Upside
High Forecast$6.00
Average Forecast$3.62
Low Forecast$1.85

According to the 3 analysts' twelve-month price targets for Evogene, the average price target is $3.62. The highest price target for EVGN is $6.00, while the lowest price target for EVGN is $1.85. The average price target represents a forecasted upside of 502.88% from the current price of $0.60.

TypeCurrent Forecast
7/21/23 to 7/20/24
1 Month Ago
6/21/23 to 6/20/24
3 Months Ago
4/22/23 to 4/21/24
1 Year Ago
7/21/22 to 7/21/23
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$3.62$3.62$3.62$5.67
Forecasted Upside502.88% Upside361.51% Upside361.51% Upside437.63% Upside
Get Evogene Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter.

EVGN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EVGN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Evogene Stock vs. The Competition

TypeEvogeneMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.72
2.51
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside502.88% Upside3,282.90% Upside10.04% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/2/2023Alliance Global Partners
1 of 5 stars
 Initiated CoverageBuy$1.85+215.43%
8/18/2023Lake Street Capital
3 of 5 stars
 Boost TargetBuy ➝ Buy$2.00 ➝ $3.00+372.81%
7/21/2023Roth Mkm
1 of 5 stars
 Boost TargetBuy$1.00 ➝ $6.00+430.97%
9/12/2022Aegis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$10.00 ➝ $8.00+699.99%
9/2/2022Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$6.00 ➝ $3.00+197.03%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:57 PM ET.

EVGN Forecast - Frequently Asked Questions

What is Evogene's forecast for 2024?

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Evogene is $3.62, with a high forecast of $6.00 and a low forecast of $1.85.

Should I buy or sell Evogene stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evogene in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EVGN shares.

Does Evogene's stock price have much upside?

According to analysts, Evogene's stock has a predicted upside of 361.51% based on their 12-month stock forecasts.

Do Wall Street analysts like Evogene more than its competitors?

Analysts like Evogene more than other "medical" companies. The consensus rating for Evogene is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how EVGN compares to other companies.


This page (NASDAQ:EVGN) was last updated on 7/20/2024 by MarketBeat.com Staff

From Our Partners